At present, IPMN is broadly divided into two main types: main duct and branch duct. However, as discussed below, the definition of mixed-type IPMN is gradually becoming accepted. In main duct IPMN, the main pancreatic duct is very dilated, while in branch duct IPMN, the branches of the pancreatic duct are dilated, resembling a bunch of grapes.IPMN is most frequently diagnosed in the elderly (around 65 years old), and the male to female ratio is 2:1, indicating that the incidence of the disease is twofold higher in males than in females. IPMN most commonly originates in the head of the pancreas, and approximately 70% of IPMN lesions are found in the head of the pancreas. It also tends to occur in multiple sites.With regard to imaging, endosc...
Pancreatic intraductal papillary mucinous neoplasms (IPMN) are cystic tumors of the pancreas charac...
Abstract Intraductal papillary mucinous neoplasm of the Pancreas (IPMN) is a potentially malignant ...
The literature is highly conflicted on what percentage of pancreatic ductal adenocarcinomas (PDACs) ...
At present, IPMN is broadly divided into two main types: main duct and branch duct. However, as disc...
Background No previous studies have examined the possible relationship between intraductal papillary...
Background No previous studies have examined the possible relationship between intraductal papillary...
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas originate from the mucinous epithe...
Background: With the use of modern cross-sectional abdominal imaging modalities, an increasing numbe...
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can progress to i...
Macrocystic pancreatic tumors seem to play an important role among neoplastic lesions of the pancrea...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
The introduction of the exocrine pancreatic classification by the World Health Organization and impr...
Although considerable progress has been made in our understanding of intraductal papillary mucinous ...
In the last decade, intraductal papillary mucinous neoplasms (IPMNs) have become commonly diagnosed....
The purpose of this study was to clarify the biological behaviour of branch duct type intraductal pa...
Pancreatic intraductal papillary mucinous neoplasms (IPMN) are cystic tumors of the pancreas charac...
Abstract Intraductal papillary mucinous neoplasm of the Pancreas (IPMN) is a potentially malignant ...
The literature is highly conflicted on what percentage of pancreatic ductal adenocarcinomas (PDACs) ...
At present, IPMN is broadly divided into two main types: main duct and branch duct. However, as disc...
Background No previous studies have examined the possible relationship between intraductal papillary...
Background No previous studies have examined the possible relationship between intraductal papillary...
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas originate from the mucinous epithe...
Background: With the use of modern cross-sectional abdominal imaging modalities, an increasing numbe...
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can progress to i...
Macrocystic pancreatic tumors seem to play an important role among neoplastic lesions of the pancrea...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
The introduction of the exocrine pancreatic classification by the World Health Organization and impr...
Although considerable progress has been made in our understanding of intraductal papillary mucinous ...
In the last decade, intraductal papillary mucinous neoplasms (IPMNs) have become commonly diagnosed....
The purpose of this study was to clarify the biological behaviour of branch duct type intraductal pa...
Pancreatic intraductal papillary mucinous neoplasms (IPMN) are cystic tumors of the pancreas charac...
Abstract Intraductal papillary mucinous neoplasm of the Pancreas (IPMN) is a potentially malignant ...
The literature is highly conflicted on what percentage of pancreatic ductal adenocarcinomas (PDACs) ...